Literature DB >> 23282211

Cocoon-like fibroadhesive tuberculous peritonitis in a peritoneal dialysis patient.

Wei-Cheng Tseng1, Der-Cherng Tarng.   

Abstract

Tuberculous peritonitis is a devastating complication of peritoneal dialysis (PD). Presentations of tuberculous peritonitis range from the common wet ascitic form to the rare fibroadhesive form, which is clinically indistinguishable from encapsulating peritoneal sclerosis. We describe a 76-year-old man on continuous ambulatory PD for three months developing wet ascitic form of tuberculous peritonitis. Three weeks after institution of antituberculous therapy and removal of PD catheter, his abdominal pain recurred and an encapsulating peritoneal sclerosis-like intestinal obstruction was noted. A rare fibroadhesive form of tuberculous peritonitis associated with the paradoxical response to antituberculous therapy was considered by excluding noncompliance, drug resistance and adverse effects, and other concomitant infections. After surgical enterolysis and continuation of antituberculous treatment, he recovered uneventfully. Our case might be the first report regarding paradoxical deterioration to antituberculous treatment in dialysis patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23282211     DOI: 10.4077/CJP.2012.BAA060

Source DB:  PubMed          Journal:  Chin J Physiol        ISSN: 0304-4920            Impact factor:   1.764


  2 in total

1.  Laparoscopic-assisted catheter insertion for continuous ambulatory peritoneal dialysis: A case report of simple technique for optimal placement.

Authors:  Tomohide Hori; Masaya Nakauchi; Kazuhiro Nagao; Fumitaka Oike; Takahiro Tanaka; Daigo Gunji; Noriyuki Okada
Journal:  World J Gastrointest Surg       Date:  2013-10-27

2.  Sclerosing encapsulating peritonitis presenting with paroxysmal abdominal pain and strangulated mechanical bowel obstruction: A case report.

Authors:  Hua Tang; Rong Xia; Shuyu Xu; Chenzhe Tao; Chao Wang
Journal:  Medicine (Baltimore)       Date:  2021-02-26       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.